This is an archived document. The links are no longer being updated.
TB Notes 3, 2002
New CDC Publications
Bock NN, Sterling TR, Hamilton CD, Pachucki C, Wang YC, Conwell
DS, Mosher A, Samuels M, and Vernon A. A prospective, randomized,
double-blind study of the tolerability of rifapentine 600, 900,
and 1,200 mg plus isoniazid in the continuation phase of tuberculosis
treatment. Am J Respir Crit Care Med 2002 Jun 1; 165 (11):
CDC. Acquired rifamycin resistance in persons with advanced HIV
disease being treated for active tuberculosis with intermittent
rifamycin-based regimens. [Notice to readers.] MMWR 2002;51(10):214-215.
CDC. Guidelines for preventing opportunistic infections among HIV-infected
persons — 2002. MMWR 2002; 51 (No. RR-8).
CDC. Progress toward TB control — India, 2001. MMWR 2002;51(11):229-232.
CDC. Progressing toward tuberculosis elimination in low-incidence
areas of the United States. MMWR 2002;51(No. RR-5).
CDC. Tuberculosis morbidity among U.S.-born and foreign-born populations
— United States, 2000. MMWR 2002;51(5):101-104.
CDC. Tuberculosis outbreak on an American Indian reservation —
Montana, 2000-2001. MMWR 2002;51(11):232-234.
CDC. World TB Day — March 24, 2002. [Box.] MMWR 2002;51(11).
Fitzpatrick LK, Okwera A, Mugerwa R, Ridzon R, Ehiner J, and Onorato
I. An investigation of suspected exogenous reinfection in tuberculosis
patients in Kampala, Uganda. Int J Tuberc Lung Dis 2002 Jun;
6 (6): 550-2.
Reichler MR, Reves R, Bur S, Ford J, Thompson V, Mangura B, Onorato
IM, Valway SE, for the Contact Investigation Study Group. Treatment
of latent tuberculosis infection in contacts of new tuberculosis
cases in the United States. Southern Medical Journal 2002;
95 (4): 414-420.
Reichler M, Taylor Z, Castro KG. Factors in tuberculosis contact
investigations. [Letter to the editor.] JAMA 2002; 287 (22):2944-45.
Saraiya M, Cookson ST, Tribble P, Silk B, Cass R, Poonja S, Walting
M, Howland N, Paz EA, Cochran J, Moser KS, Oxtoby MJ, Binkin NJ.
Tuberculosis screening among foreign-born persons applying for permanent
US residence. Am J Public Health 2002; 92(5): 826-829.
The Tuberculosis Trials Consortium. Rifapentine and isoniazid once
a week versus rifampicin and isoniazid twice a week for treatment
of susceptible pulmonary tuberculosis in HIV-negative patients:
a randomised clinical trial. Lancet 2002; 360: 528-34.
Released October 2008
Centers for Disease Control and Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination - http://www.cdc.gov/tb
Please send comments/suggestions/requests
CDC/Division of Tuberculosis Elimination
Communications, Education, and Behavioral Studies Branch
1600 Clifton Rd., NE - Mailstop E-10, Atlanta, GA 30333